Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04331002 · ClinicalTrials.gov registry record · Phase 2
Success of Long-acting Anti-inflammatories After Anterior Cruciate Ligament and Meniscal Injury
A Phase 2 study, sponsored by Austin V Stone.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT04331002: Clinical Trial Phase 2 study, sponsored by Austin V Stone.
NCT04331002 is a Phase 2 study that was terminated before completion, run by Austin V Stone. The registered enrollment target is 1 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04331002, a Phase 2 study, was terminated before completion, sponsored by Austin V Stone.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if extended-release triamcinolone acetonide treatment alters the progressive changes in bone shape previously demonstrated after anterior cruciate ligament (ACL) reconstruction with partial meniscectomy or meniscal repair.
Primary Outcome
Using manual segmentation, the volume of the medial femoral condyle will be quantified from 3-Tesla magnetic resonance imaging (MRI) scans performed before and 4 months after the study injection. Medial condyle volume will be expressed as cm3.
Interventions
- OTHER Placebo
- DRUG Zilretta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2020-08-21 |
| Est. Completion | 2022-07-11 |
| Phase | Phase 2 |
Why NCT04331002 stopped before completion
NCT04331002 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04331002 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04331002 about?
NCT04331002 is a clinical study titled "Success of Long-acting Anti-inflammatories After Anterior Cruciate Ligament and Meniscal Injury". The purpose of this study is to determine if extended-release triamcinolone acetonide treatment alters the progressive changes in bone shape previously demonstrated after anterior cruciate ligament (ACL) reconstruction with partial meniscectomy or meniscal repair.
What is the current status of trial NCT04331002?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2020-08-21. Estimated completion is 2022-07-11.
What interventions are being tested in trial NCT04331002?
The interventions under investigation include: Placebo (OTHER), Zilretta (DRUG).
Who is sponsoring clinical trial NCT04331002?
This trial is sponsored by Austin V Stone, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04331002's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI